ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0288

Targeted Sequencing Revealed Novel Candidate Genetic Contributions to Lupus Nephritis in a Cohort of Swedish Patients with Systemic Lupus Erythematosus

Sule Yavuz1, Pascal Pucholt2, Dag Leonard2, Juliana Imgenberg-Kreuz2, Matteo Bianchi2, Johanna Sandling2, Iva Gunnarsson3, Swedish Sle Network2 and Lars Ronnblom2, 1Uppsala University Rheumatology, Doral, FL, 2Uppsala University, Uppsala, Sweden, 3Karolinska Institute, Stockholm, Sweden

Meeting: ACR Convergence 2020

Keywords: genetics, Lupus nephritis

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Friday, November 6, 2020

Title: SLE – Etiology & Pathogenesis Poster

Session Type: Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Lupus nephritis (LN) is a common debilitating manifestation of Systemic Lupus Erythematosus (SLE). Despite improved understanding of underlying mechanisms driving to LN and early treatment strategies, yet 10% of LN patients progress to end-stage renal disease (ESRD) in 5 years after the onset of LN[1]

Methods: To explore novel genetic associations, we performed a case-case analysis in a quality-controlled dataset of 958 Swedish patients with SLE (337 with LN) and 1030 healthy individuals. We stratified patients based on their histopathologic phenotype as proliferative, pure membranous LN, and ESDR. Mixed phenotypes were excluded. Targeted capture and enrichment was performed using a NimbleGen array, including 1853 genes selected based on their known involvement in systemic inflammatory autoimmune diseases. Variant and gene-level aggregate association testing were performed separately using Plink and SKAT-O respectively[2].

Results: We identified seven candidate loci (P ≤ 1× 10− 5) associated with proliferative nephritis, five with membranous nephritis, and seven with ESRD. The strongest associations with proliferative nephritis, membranous nephritis, and ESRD corresponded to chr14q23.3 (p=5.58×10-6 ), LTF (p =1.64×10-6 ), and MERTK(p=9.52×10-6), respectively. The gene-based aggregate association, which potentiates the power to detect gene regions with aggregation of functional common and rare variants revealed two additional potentially novel genes, CTF1 (p= 2.97×10-5, FDR=0.03) and FBXL19 (3.14×10-5, FDR=0.03),  that were associated with membranous nephritis.

Conclusion: We revealed novel genetic risk loci in association with ESRD and candidate genes in association with membranous nephritis in Swedish SLE patients.  

1.Davidson A, Aranow C, Mackay M. Lupus nephritis: challenges and progress. Curr Opin Rheumatol. 2019 Aug.

2.Lee S, Emond MJ, Bamshad MJ, Barnes KC, Rieder MJ, Nickerson DA, et al. Optimal unified approach for rare-variant association testing with application to small-sample case-control whole-exome sequencing studies. Am J Hum Genet. 2012 Aug; 91(2):224-237.


Disclosure: S. Yavuz, None; P. Pucholt, None; D. Leonard, None; J. Imgenberg-Kreuz, None; M. Bianchi, None; J. Sandling, None; I. Gunnarsson, None; S. Sle Network, None; L. Ronnblom, None.

To cite this abstract in AMA style:

Yavuz S, Pucholt P, Leonard D, Imgenberg-Kreuz J, Bianchi M, Sandling J, Gunnarsson I, Sle Network S, Ronnblom L. Targeted Sequencing Revealed Novel Candidate Genetic Contributions to Lupus Nephritis in a Cohort of Swedish Patients with Systemic Lupus Erythematosus [abstract]. Arthritis Rheumatol. 2020; 72 (suppl 10). https://acrabstracts.org/abstract/targeted-sequencing-revealed-novel-candidate-genetic-contributions-to-lupus-nephritis-in-a-cohort-of-swedish-patients-with-systemic-lupus-erythematosus/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2020

ACR Meeting Abstracts - https://acrabstracts.org/abstract/targeted-sequencing-revealed-novel-candidate-genetic-contributions-to-lupus-nephritis-in-a-cohort-of-swedish-patients-with-systemic-lupus-erythematosus/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology